A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
Clinical trial NCT06059846 · COMPLETED
Trial details
- NCT number
- NCT06059846
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-21
- Primary completion
- 2025-01-27
- Enrollment
- 1690
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.